Biotech · Private company
Shire
Track this companyFree. Adds Shire to your Dealase workspace and tells you when its record changes.
Clinical trials255 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- 25 mg OntamalimabPhase 3 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 75 mg OntamalimabPhase 3 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Budesonide oral suspensionPhase 3 · Eosinophilic Esophagitis (EoE)ClinicalTrials.gov · fetched Nov 12, 2026
- ElaprasePhase 3 · Hunter SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Idursulfase-ITPhase 3 · Hunter SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- LanadelumabPhase 3 · AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- NeedlePhase 3 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Oral Budesonide Suspension (OBS)Phase 3 · Eosinophilic Esophagitis (EoE)ClinicalTrials.gov · fetched Nov 12, 2026
- SOCPhase 3 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- SyringePhase 3 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- TEDPhase 3 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- TeduglutidePhase 3 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- SHP611Phase 2 · Metachromatic Leukodystrophy (MLD)ClinicalTrials.gov · fetched Nov 12, 2026
- MaribavirPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Maribavir (200 mg)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Maribavir (400 mg)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Maribavir (800 mg)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- TAK-755Phase 1 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Atomoxetine hydrochlorideAttention Deficit Hyperactivity DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Elaprase for intravenous (IV) infusionHunter SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Guanfacine hydrochloride (TAK-503)Attention Deficit Hyperactivity DisorderClinicalTrials.gov · fetched Nov 12, 2026
- No InterventionHypoparathyroidismClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 14, 2021ClinicalTrials.gov NCT04683003 · fetched Nov 12, 2026
- A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-InhibitorPHASE3 · COMPLETED · started Feb 5, 2021ClinicalTrials.gov NCT04444895 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese ParticipantsPHASE1 · COMPLETED · started Aug 7, 2020ClinicalTrials.gov NCT04497883 · fetched Nov 12, 2026
- A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult ParticipantsPHASE1 · TERMINATED · started Oct 25, 2019ClinicalTrials.gov NCT04131556 · fetched Nov 12, 2026
- A Study of SHP655 (rADAMTS13) in Sickle Cell DiseasePHASE1 · COMPLETED · started Oct 21, 2019ClinicalTrials.gov NCT03997760 · fetched Nov 12, 2026
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)PHASE4 · COMPLETED · started Sep 18, 2019ClinicalTrials.gov NCT04085172 · fetched Nov 12, 2026
- A Study of Intrathecal SHP611 in Children With Metachromatic LeukodystrophyPHASE2 · COMPLETED · started May 13, 2019ClinicalTrials.gov NCT03771898 · fetched Nov 12, 2026
- A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As ChildrenNA · COMPLETED · started Nov 10, 2018ClinicalTrials.gov NCT04002531 · fetched Nov 12, 2026
- A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)PHASE3 · COMPLETED · started Feb 27, 2018ClinicalTrials.gov NCT03283085 · fetched Nov 12, 2026
- Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)PHASE3 · TERMINATED · started Oct 5, 2017ClinicalTrials.gov NCT03245840 · fetched Nov 12, 2026
- Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)PHASE3 · COMPLETED · started Jan 9, 2017ClinicalTrials.gov NCT02954458 · fetched Nov 12, 2026
- Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 StudyPHASE3 · COMPLETED · started Dec 9, 2016ClinicalTrials.gov NCT02949362 · fetched Nov 12, 2026
- An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)PHASE3 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02736409 · fetched Nov 12, 2026
- A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is AchievedPHASE3 · COMPLETED · started Dec 7, 2015ClinicalTrials.gov NCT02605837 · fetched Nov 12, 2026
- Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of AgePHASE4 · COMPLETED · started Oct 28, 2015ClinicalTrials.gov NCT02455622 · fetched Nov 12, 2026
- A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARACOMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT05556629 · fetched Nov 12, 2026
- Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094PHASE2_PHASE3 · COMPLETED · started Apr 14, 2015ClinicalTrials.gov NCT02412787 · fetched Nov 12, 2026
- Registry for Participants With Short Bowel SyndromeACTIVE_NOT_RECRUITING · started Jun 23, 2014ClinicalTrials.gov NCT01990040 · fetched Nov 12, 2026
- A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 7, 2013ClinicalTrials.gov NCT01920737 · fetched Nov 12, 2026
- Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).PHASE4 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT02141113 · fetched Nov 12, 2026
- SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic LymphomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 1, 2012ClinicalTrials.gov NCT01574274 · fetched Nov 12, 2026
- Gaucher Disease Outcome Survey (GOS)RECRUITING · started Dec 29, 2010ClinicalTrials.gov NCT03291223 · fetched Nov 12, 2026
- HEXT (Hypo EXTended): Effect of PTH on Skeleton in HypoparathyroidismPHASE3 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01199614 · fetched Nov 12, 2026
- Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue SyndromePHASE4 · COMPLETED · started Nov 1, 2009ClinicalTrials.gov NCT01071044 · fetched Nov 12, 2026
- Hunter Outcome Survey (HOS)COMPLETED · started Oct 3, 2005ClinicalTrials.gov NCT03292887 · fetched Nov 12, 2026